 |
Manageable number of monthly hair restoration surgeries illustrates ISHRS members' hands-on, expert approach
CHICAGO, June 10, 2025 /PRNewswire/ -- According to results of a new member survey conducted by the International Society of Hair Restoration Surgery (ISHRS), first-time hair restoration surgery patients in 2024 skewed younger than the general adult population, with 95% initiating hair restoration surgery between the ages of 20-35. More women also turned to a permanent solution for hair loss, as the number of female hair restoration surgical patients treated in 2024 increased by 16.5% from 2021.
ISHRS members reported continued growth in the field of hair restoration, due in large part to continual refinements in hair transplantation and a variety of effective non-surgical and medical solutions to combat hair loss. Specifically, the average number of patients per ISHRS member increased by 20% since 2021. The average number of hair restoration surgeries performed per ISHRS member per month in 2024 was 15, which reflects the hands-on nature of ISHRS physicians and their commitment to performing their own surgeries.
"People experiencing hair loss are no longer waiting until middle age to find effective solutions from trusted experts, such as ISHRS physicians who devote three-quarters of their practices to hair restoration on average," said Ricardo Mejia, MD, FISHRS, president of the ISHRS. "The reasonable caseload of hair transplantation surgeries that our members reported performing each month is a testament to their direct role in performing this highly intricate and experience-driven surgery, unlike black market hair transplant clinics where technicians illegally perform hair transplant surgeries."
Body Hair Transplantation Grows
While scalp hair transplantation remains the most popular form of hair restoration surgery, supplementing hair on other parts of the body with body hair transplantation (also referred to as non-scalp hair restoration) is attracting more interest among men and women.
- The percentage of men seeking non-scalp hair restoration procedures increased to 18% in 2024, up from 13% in 2021.
- The percentage of women seeking non-scalp hair restoration procedures increased to 21% in 2024, up from 17% in 2021.
- After scalp, the next highest percentage of transplantation to recipient area for females was eyebrows, at 12%.
- After scalp, the next highest percentage of transplantation to recipient area for males was moustache/beards, at 5%.
The Patient's Point of View
When ISHRS members were asked to provide feedback on their patients' perspectives on hair restoration surgery, the survey found that nearly half of patients were willing to discuss their procedure with others and had expressed specific reasons for undergoing the surgery.
- ISHRS members reported that 44% of the hair transplant patients they treated in 2024 planned to tell others that they had a hair transplant.
- ISHRS members reported that the number one (90%) reason their patients chose to undergo hair transplantation was to "become/feel more attractive".
- The second most common reason (63%) patients chose to have hair transplantation surgery was to "appear younger to compete in the workplace".
Black Market Continues to Impact Marketplace
Dr. Mejia noted that the number of complications from black market hair transplants is on the rise around the world, which poses serious consequences for hair loss patients. This is usually due to the delegation of unlicensed and untrained individuals who are not doctors.
- 59% of ISHRS members reported there are black market hair transplant clinics in their cities, up from 51% in 2021.
- ISHRS members reported that the average percentage of repair cases due to a previous black market hair transplant was 10%, up from 6% in 2021.
About the ISHRS
The International Society of Hair Restoration Surgery (ISHRS) is a global non-profit medical association and the leading authority on hair loss treatment and restoration with 1,200 members throughout 80 countries worldwide. Above all, the ISHRS is dedicated to achieving excellence in patient outcomes by promoting the highest standards of medical practice, medical ethics, and research in the medical hair restoration industry. The ISHRS also provides continuing medical education to physicians specializing in hair transplant surgery and is committed to delivering the latest information on medical and surgical treatments to consumers suffering from hair loss, and most commonly from androgenetic alopecia – male pattern baldness and female pattern hair loss. It was founded in 1993 as the first international society to promote continuing quality improvement and education for professionals in the field of hair restoration surgery. For more information and to locate a physician, visit www.ishrs.org.
About the Survey
Conducted by Relevant Research Consulting of Evanston, IL, USA, the ISHRS 2025 Practice Census is a compilation of information provided solely by participating physicians. The information published in this survey was developed from actual historical information and does not include any projected information. The margin of error for the sample is within plus or minus 5.4 percent at the 95 percent confidence level. For a full reprint of the ISHRS 2025 Practice Census Report, visit Hair Restoration Statistics.
Manageable number of monthly hair restoration surgeries illustrates ISHRS members' hands-on, expert approach
CHICAGO, June 10, 2025 /PRNewswire/ -- According to results of a new member survey conducted by the International Society of Hair Restoration Surgery (ISHRS), first-time hair restoration surgery patients in 2024 skewed younger than the general adult population, with 95% initiating hair restoration surgery between the ages of 20-35. More women also turned to a permanent solution for hair loss, as the number of female hair restoration surgical patients treated in 2024 increased by 16.5% from 2021.
ISHRS members reported continued growth in the field of hair restoration, due in large part to continual refinements in hair transplantation and a variety of effective non-surgical and medical solutions to combat hair loss. Specifically, the average number of patients per ISHRS member increased by 20% since 2021. The average number of hair restoration surgeries performed per ISHRS member per month in 2024 was 15, which reflects the hands-on nature of ISHRS physicians and their commitment to performing their own surgeries.
"People experiencing hair loss are no longer waiting until middle age to find effective solutions from trusted experts, such as ISHRS physicians who devote three-quarters of their practices to hair restoration on average," said Ricardo Mejia, MD, FISHRS, president of the ISHRS. "The reasonable caseload of hair transplantation surgeries that our members reported performing each month is a testament to their direct role in performing this highly intricate and experience-driven surgery, unlike black market hair transplant clinics where technicians illegally perform hair transplant surgeries."
Body Hair Transplantation Grows
While scalp hair transplantation remains the most popular form of hair restoration surgery, supplementing hair on other parts of the body with body hair transplantation (also referred to as non-scalp hair restoration) is attracting more interest among men and women.
- The percentage of men seeking non-scalp hair restoration procedures increased to 18% in 2024, up from 13% in 2021.
- The percentage of women seeking non-scalp hair restoration procedures increased to 21% in 2024, up from 17% in 2021.
- After scalp, the next highest percentage of transplantation to recipient area for females was eyebrows, at 12%.
- After scalp, the next highest percentage of transplantation to recipient area for males was moustache/beards, at 5%.
The Patient's Point of View
When ISHRS members were asked to provide feedback on their patients' perspectives on hair restoration surgery, the survey found that nearly half of patients were willing to discuss their procedure with others and had expressed specific reasons for undergoing the surgery.
- ISHRS members reported that 44% of the hair transplant patients they treated in 2024 planned to tell others that they had a hair transplant.
- ISHRS members reported that the number one (90%) reason their patients chose to undergo hair transplantation was to "become/feel more attractive".
- The second most common reason (63%) patients chose to have hair transplantation surgery was to "appear younger to compete in the workplace".
Black Market Continues to Impact Marketplace
Dr. Mejia noted that the number of complications from black market hair transplants is on the rise around the world, which poses serious consequences for hair loss patients. This is usually due to the delegation of unlicensed and untrained individuals who are not doctors.
- 59% of ISHRS members reported there are black market hair transplant clinics in their cities, up from 51% in 2021.
- ISHRS members reported that the average percentage of repair cases due to a previous black market hair transplant was 10%, up from 6% in 2021.
About the ISHRS
The International Society of Hair Restoration Surgery (ISHRS) is a global non-profit medical association and the leading authority on hair loss treatment and restoration with 1,200 members throughout 80 countries worldwide. Above all, the ISHRS is dedicated to achieving excellence in patient outcomes by promoting the highest standards of medical practice, medical ethics, and research in the medical hair restoration industry. The ISHRS also provides continuing medical education to physicians specializing in hair transplant surgery and is committed to delivering the latest information on medical and surgical treatments to consumers suffering from hair loss, and most commonly from androgenetic alopecia – male pattern baldness and female pattern hair loss. It was founded in 1993 as the first international society to promote continuing quality improvement and education for professionals in the field of hair restoration surgery. For more information and to locate a physician, visit www.ishrs.org.
About the Survey
Conducted by Relevant Research Consulting of Evanston, IL, USA, the ISHRS 2025 Practice Census is a compilation of information provided solely by participating physicians. The information published in this survey was developed from actual historical information and does not include any projected information. The margin of error for the sample is within plus or minus 5.4 percent at the 95 percent confidence level. For a full reprint of the ISHRS 2025 Practice Census Report, visit Hair Restoration Statistics.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
New Survey Finds Younger Adults, More Women Seeking Treatment for Hair Loss
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
